Primary FDA-Approved Indications
Treatment is typically twice daily for 5 days; post‑exposure prophylaxis is once daily for about 10 days in close contacts when indicated.
Treatment of influenza A and B
FDA ApprovedInfants, children, adolescentsFirst-line
High‑risk children and severe disease may benefit even if therapy starts later